Skip to main content

Advertisement

SpringerLink
Log in

MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

In human esophageal squamous cell carcinoma (ESCC), miR-34a was downregulated and could inhibit in vitro cell proliferation and migration. However, the underlying mechanism was not clear yet. The expression levels of mRNA and protein were detected by quantitative real-time PCR or western blotting, respectively. MiR-34a was knocked down or overexpressed and transfected into human ESCC cell lines ECA109 and TE-13, respectively. Cell migration and wound healing assays were used to examine the effect on migration and invasion in vitro. Animal models were used to examine the role of miR-34a in metastasis in vivo. Luciferase assay was carried out to validate the potential target of miR-34a. CD44 was upregulated and miR-34a was downregulated in ESCC tissues and cell lines. The linear regression analysis showed that CD44 expression was negatively correlated with the level of miR-34a. Luciferase assay showed that miR-34a interacted with a putative binding site in the CD44 3′UTR. MiR-34a was found to negatively regulate the expression of CD44. In vitro experiment showed that miR-34a overexpression inhibited ESCC cell invasion and migration; whereas miR-34a knockdown showed reversed results. MiR-34a also inhibited esophagus tumor growth and metastasis in vivo; whereas miR-34a knockdown showed reversed results. Finally, we found that CD44 knockdown reversed the effects of miR-34a knockdown on ESCC cell invasion and migration in vitro. MiRNA-34a suppresses invasion and metastatic in ESCC by regulating CD44.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Arnold M, Soerjomataram I, Ferlay J, Forman D (2015) Global incidence of oesophageal cancer by histological subtype in 2012. Gut 64:381

    Article  PubMed  Google Scholar 

  2. Lagergren J (2015) Oesophageal cancer in 2014: advances in curatively intended treatment. Nat Rev Gastroenterol Hepatol 12:74–75

    Article  PubMed  Google Scholar 

  3. Li B, Xu WW, Han L, Chan KT, Tsao SW, Lee NP, Law S, Xu LY, Li EM, Chan KW (2017) MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF. Oncogene 36(28):3986–4000

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Calin GA, Croce CM (2006) MicroRNA-cancer connection: the beginning of a new tale. Can Res 66:7390–7394

    Article  CAS  Google Scholar 

  5. Yu T, Liu K, Wu Y, Fan J, Chen J, Li C, Yang Q, Wang Z (2013) MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway. Oncogene 33(42):5017–5027

    Article  PubMed  Google Scholar 

  6. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102:13944–13949

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Si M, Zhu S, Wu H, Lu Z, Wu F, Mo Y (2007) miR-21-mediated tumor growth. Oncogene 26:2799–2803

    Article  CAS  PubMed  Google Scholar 

  8. Cho WC, Chow AS, Au JS (2009) Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur J Cancer 45:2197–2206

    Article  CAS  PubMed  Google Scholar 

  9. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA, Hannon GJ (2007) A microRNA component of the p53 tumour suppressor network. Nature 447:1130–1134. https://doi.org/10.1038/nature05939

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, Körner H, Knyazev P, Diebold J, Hermeking H (2008) Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7:2591

    Article  CAS  PubMed  Google Scholar 

  11. Ma Y, Qin H, Cui Y (2013) MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3 K/Akt/Bad pathway. Biochem Biophys Res Commun 441:958–963. https://doi.org/10.1016/j.bbrc.2013.11.010

    Article  CAS  PubMed  Google Scholar 

  12. Lin X, Xu XY, Chen QS, Huang C (2015) Clinical significance of microRNA-34a in esophageal squamous cell carcinoma. Genet Mol Res Gmr 14:17684

    Article  CAS  PubMed  Google Scholar 

  13. Hu Y, Correa AM, Hoque A, Guan B, Ye F, Huang J, Swisher SG, Wu TT, Ajani JA, Xu XC (2011) Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer 128:132–143

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Li J, Wang K, Chen X, Meng H, Song M, Wang Y, Xu X, Bai Y (2012) Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells. BMC Mol Biol 13:4

    Article  PubMed  PubMed Central  Google Scholar 

  15. Shi H, Zhou S, Liu J, Zhu J, Xue J, Gu L, Chen Y (2016) miR-34a inhibits the in vitro cell proliferation and migration in human esophageal cancer. Pathol Res Pract 212:444–449. https://doi.org/10.1016/j.prp.2016.02.019

    Article  CAS  PubMed  Google Scholar 

  16. Zhao H, Ma B, Wang Y, Han T, Zheng L, Sun C, Liu T, Zhang Y, Qiu X, Fan Q (2013) miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44. Oncol Rep 29:1027–1036

    Article  CAS  PubMed  Google Scholar 

  17. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303

    Article  CAS  PubMed  Google Scholar 

  18. Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4:33

    Article  CAS  PubMed  Google Scholar 

  19. Marhaba R, Zöller M (2004) CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol 35:211–231

    Article  CAS  PubMed  Google Scholar 

  20. Olsson E, Honeth G, Bendahl P, Lao HS, Gruvbergersaal S, Ringnér M, Vallonchristersson J, Jönsson G, Holm K, Lövgren K (2011) CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers. BMC Cancer 11:418

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Heyse TJ, Malcherczyk D, Moll R, Timmesfeld N, Wapelhorst J, Fuchs-Winkelmann S, Paletta JR, Schofer MD (2010) CD44: survival and metastasis in chondrosarcoma. Osteoarthr Cartil 18:849–856

    Article  CAS  PubMed  Google Scholar 

  22. Liu C, Kelnar K, Liu B, Xin C, Calhoundavis T, Li H, Patrawala L, Hong Y, Jeter C, Honorio S (2011) The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 186:211

    Article  Google Scholar 

  23. Shi Y, Liu C, Liu X, Tang DG, Wang J (2014) The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells. PLoS ONE 9:e90022

    Article  PubMed  PubMed Central  Google Scholar 

  24. Gan Y, Yao W, Wei X, Li H, Hua X, Lang B (2014) MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44. J Exp Clin Cancer Res 33:779

    Article  Google Scholar 

  25. Nie J, Ge X, Geng Y, Cao H, Zhu W, Jiao Y, Wu J, Zhou J, Cao J (2015) miR-34a inhibits the migration and invasion of esophageal squamous cell carcinoma by targeting Yin Yang-1. Oncol Rep 34:311

    Article  CAS  PubMed  Google Scholar 

  26. Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y, Zheng X (2009) miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett 275(1):44–53

    Article  CAS  PubMed  Google Scholar 

  27. Jia L, Wei S, Mitchelson K, Gao Y, Zheng Y, Meng Z, Gan Y, Yu G (2014) miR-34a inhibits migration and invasion of tongue squamous cell carcinoma via targeting MMP9 and MMP14. PLoS ONE 9:e108435

    Article  PubMed  PubMed Central  Google Scholar 

  28. Lai M, Du G, Shi R, Yao J, Yang G, Wei Y, Zhang D, Xu Z, Zhang R, Li Y (2015) miR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells. Mol Med Rep 11:3301–3307

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Atala A (2011) Re: the MicroRNA miR-34a Inhibits Prostate Cancer Stem Cells and Metastasis by Directly Repressing CD44. J Urol 17:211

    Google Scholar 

  30. Gaur S (2014) The Role of MIR-34a in inhibition of prostate tumor growth in the bone and Induction of Autophagy. UT GSBS Dissertations and Theses. Paper 523

  31. Jing YK, Wei W, Huynh HD, Jin Z, Wang X, Chang TC, Xie X, He L, Mangala LS, Lopezberestein G (2015) Abstract P6-17-01: MicroRNA-34a suppresses breast cancer bone metastasis by inhibiting osteoclastogenesis and targeting tgif2. Cancer Res 75:P6-17-01-P6-17-01

    Article  Google Scholar 

  32. Xiao X, Huang X, Ye F, Chen B, Song C, Wen J, Zhang Z, Zheng G, Tang H, Xie X (2016) The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer. Sci Rep 6:21735

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Yan K, Gao J, Yang T, Ma Q, Qiu X, Fan Q, Ma B (2012) MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS ONE 7:e33778

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Zhao Y, Tu MJ, Wang WP, Qiu JX, Yu AX, Yu AM (2016) Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest. Sci Rep 6:26611

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20. https://doi.org/10.1016/j.cell.2004.12.035

    Article  CAS  PubMed  Google Scholar 

  36. Sun F, Fu H, Liu Q, Tie Y, Zhu J, Xing R, Sun Z, Zheng X (2008) Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett 582:1564–1568. https://doi.org/10.1016/j.febslet.2008.03.057

    Article  CAS  PubMed  Google Scholar 

  37. Wei JS, Song YK, Durinck S, Chen QR, Cheuk AT, Tsang P, Zhang Q, Thiele CJ, Slack A, Shohet J, Khan J (2008) The MYCN oncogene is a direct target of miR-34a. Oncogene 27:5204–5213. https://doi.org/10.1038/onc.2008.154

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Yamakuchi M, Ferlito M, Lowenstein CJ (2008) miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 105:13421–13426. https://doi.org/10.1073/pnas.0801613105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Yu G, Li H, Wang J, Gumireddy K, Li A, Yao W, Tang K, Xiao W, Hu J, Xiao H (2014) miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells. J Urol 192:1229–1237

    Article  CAS  PubMed  Google Scholar 

  40. Li H, Yu G, Shi R, Lang B, Chen X, Xia D, Xiao H, Guo X, Guan W, Ye Z (2014) Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy. Mol Cancer 13:8

    Article  PubMed  PubMed Central  Google Scholar 

  41. Louderbough JM, Schroeder JA (2011) Understanding the dual nature of CD44 in breast cancer progression. Mol Cancer Res 9:1573–1586. https://doi.org/10.1158/1541-7786.mcr-11-0156

    Article  CAS  PubMed  Google Scholar 

  42. Su YJ, Lai HM, Chang YW, Chen GY, Lee JL (2011) Direct reprogramming of stem cell properties in colon cancer cells by CD44. EMBO J 30:3186–3199. https://doi.org/10.1038/emboj.2011.211

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Li C, Lee CJ, Simeone DM (2009) Identification of human pancreatic cancer stem cells. Methods Mol Biol 568:161–173. https://doi.org/10.1007/978-1-59745-280-9_10

    Article  CAS  PubMed  Google Scholar 

  44. Palapattu GS, Wu C, Silvers CR, Martin HB, Williams K, Salamone L, Bushnell T, Huang LS, Yang Q, Huang J (2009) Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer. Prostate 69:787–798. https://doi.org/10.1002/pros.20928

    Article  CAS  PubMed  Google Scholar 

  45. Chen W, Zhang X, Chu C, Cheung WL, Ng L, Lam S, Chow A, Lau T, Chen M, Li Y, Nie Y, Wong BC, Pang R (2013) Identification of CD44 + cancer stem cells in human gastric cancer. Hepatogastroenterology 60:949–954. https://doi.org/10.5754/hge12881

    CAS  PubMed  Google Scholar 

  46. Hu B, Luo W, Hu RT, Zhou Y, Qin SY, Jiang HX (2015) Meta-analysis of prognostic and clinical significance of CD44v6 in esophageal cancer. Medicine 94:e1238

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Fujiwara Y, Yoshikawa R, Tsujie M, Kato H, Takeyama H, Kitani K, Yukawa M and Inoue M (2015) CD44, a cancer stemness marker, to predict poor clinical outcome of esophageal cancer patients after neoadjuvant chemoradiotherapy. http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/e15068

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, First Affiliated Hospital of Anhui Medical University, 218 Jixi Rd, Hefei, 230022, Anhui, People’s Republic of China

    Jianhui Zuo, Kechao Zhu, Yunhai Wang & Zaicheng Yu

Authors
  1. Jianhui Zuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kechao Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yunhai Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zaicheng Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zaicheng Yu.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zuo, J., Zhu, K., Wang, Y. et al. MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44. Mol Cell Biochem 443, 139–149 (2018). https://doi.org/10.1007/s11010-017-3218-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-017-3218-3

Keywords

Search

Navigation